A Case of Typhlitis Developed after Chemotherapy with Irinotecan and Cisplatin in a Patient with Small Cell Lung Carcinoma / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
;
: 288-291, 2012.
Artículo
en Inglés
| WPRIM
| ID: wpr-10264
ABSTRACT
Typhlitis is a necrotizing colitis that usually occurs in neutropenic patients and develops most often in patients with hematologic malignancies such as leukemia and lymphoma. Typhlitis may proceed to bowel perforation, peritonitis and sepsis, which requires immediate treatment. Irinotecan is a semisynthetic analogue of the natural alkaloid camptothecin which prevents DNA from unwinding by inhibition of topoisomerase I. It is mainly used in colon cancer and small cell lung carcinoma (SCLC), of which the most common adverse effects are gastrointestinal toxicities. To the best of our knowledge, no case of typhlitis after chemotherapy with a standard dose of irinotecan in a solid tumor has been reported in the literature. We, herein, report the first case of typhlitis developed after chemotherapy combining irinotecan and cisplatin in a patient with SCLC.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Peritonitis
/
Camptotecina
/
ADN
/
Leucemia
/
Cisplatino
/
Colitis
/
Neoplasias del Colon
/
ADN-Topoisomerasas de Tipo I
/
Sepsis
/
Neoplasias Hematológicas
Límite:
Humanos
Idioma:
Inglés
Revista:
Tuberculosis and Respiratory Diseases
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS